Amnioquick® is a simple and rapid in vitro test for detection of premature rupture of foetal membranes (PROM) in pregnant woman. PROM can occur in 5- 10% of pregnancy cases, which could result in preterm delivery and foetal infection. Accurate diagnosis is essential for proper management of PROM.
Amnioquick® is a simple, rapid and sensitive test for detection of Insulin Growth Factor Binding Protein-1 (IGFBP-1) from vaginal swab samples. Based on monoclonal antibody technology Amnioquick® can detect IGFBP-1 at concentrations of 5 ng/mL test with no interference from other proteins. The test is sensitive enough to detect IGFBP-1 in a few microliters of amniotic fluid.